ClinicalTrials.Veeva

Menu
P

Profound Research | Dermatologist Medical Group of North County - Oceanside, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY3537982
Pembrolizumab
Descartes-08
PF-07264660
Sacituzumab
PF-07275315

Parent organization

This site is a part of Profound Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 9 total trials

A Study of Barzolvolimab in Patients With Prurigo Nodularis

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.

Enrolling
Prurigo Nodularis
Other: Matching Placebo
Biological: barzolvolimab

This study will evaluate the safety and efficacy of empasiprubart compared with placebo in adult participants with dermatomyositis (DM).The study dur...

Active, not recruiting
Myositis
Dermatomyositis
Other: Placebo IV
Biological: Empasiprubart IV

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Atopic Dermatitis
Drug: PF-07275315
Other: Placebo

This is a Phase II study to evaluate the safety, tolerability and manufacturing feasibility of Descartes-08 CAR T-cells in patients with Systematic L...

Enrolling
Systemic Lupus Erythematosus (SLE)
Drug: Descartes-08
Locations recently updated

This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizu...

Enrolling
Triple-Negative Breast Cancer
Biological: Pembrolizumab
Biological: Sacituzumab tirumotecan

The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the pembrolizumab and placebo comb...

Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: Olomorasib
Drug: Placebo

The purpose of this study is to compare pembrolizumab (MK-3475) in combination with sacituzumab govitecan with pembrolizumab alone with respect to pr...

Enrolling
Carcinoma, Non-Small-Cell Lung
Biological: Pembrolizumab
Biological: Sacituzumab Govitecan

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidat...

Enrolling
Acne
Other: Placebo
Biological: Acne mRNA vaccine

Trial sponsors

Merck Sharp & Dohme (MSD) logo
C
Celldex Therapeutics logo
C
Lilly logo
Pfizer logo
Sanofi logo
argenx logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems